{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T13:25:20Z","timestamp":1795181120102,"version":"4.10.3"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014825","name":"Biotechnology Industry Research Assistance Council","doi-asserted-by":"publisher","award":["BT\/NBM\/0097\/02\/18"],"award-info":[{"award-number":["BT\/NBM\/0097\/02\/18"]}],"id":[{"id":"10.13039\/501100014825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.humimm.2026.112082","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:16:19Z","timestamp":1790331379000},"page":"112082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterogeneous serotype-specific immune responses following sequential PCV13-PPSV23 vaccination in adults with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"87","author":[{"given":"Shincy M.","family":"Ramakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhila M.","family":"Mavuppadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Govindan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vani","family":"Rajashekaraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadahalli Lingegowda","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.humimm.2026.112082_bb0005","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.humimm.2026.112082_bb0010","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.vaccine.2021.01.066","article-title":"Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries","volume":"39","author":"Sauer","year":"2021","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.humimm.2026.112082_bb0015","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.2337\/db14-0020","article-title":"Diabetes and cardiovascular disease in older adults: current status and future directions","volume":"63","author":"Halter","year":"2014","journal-title":"Diabetes"},{"issue":"Issue 1","key":"10.1016\/j.humimm.2026.112082_bb0020","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.humimm.2026.112082_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(13)70046-9","article-title":"Diabetes and risk of physical disability in adults: a systematic review and meta-analysis","volume":"1","author":"Wong","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.humimm.2026.112082_bb0030","first-page":"1","article-title":"Cost of diabetes mellitus in Africa: a systematic review of existing literature, global","volume":"14","author":"Mutyambizi","year":"2018","journal-title":"Health"},{"key":"10.1016\/j.humimm.2026.112082_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"11","key":"10.1016\/j.humimm.2026.112082_bb0040","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.4103\/ijo.IJO_1627_21","article-title":"Epidemiology of type 2 diabetes in India","volume":"69","author":"Pradeepa","year":"2021","journal-title":"Indian J. Ophthalmol."},{"issue":"8","key":"10.1016\/j.humimm.2026.112082_bb0045","first-page":"859","article-title":"Diabetes mellitus and pneumococcal pneumonia","volume":"14","author":"Cilloniz","year":"2024","journal-title":"Diagnostics (Basel, Switzerland)"},{"key":"10.1016\/j.humimm.2026.112082_bb0050","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5052812","article-title":"The imbalance of B-lymphocyte subsets in subjects with different glucose tolerance: relationship with metabolic parameter and disease status","volume":"2017","author":"Deng","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"11","key":"10.1016\/j.humimm.2026.112082_bb0055","first-page":"1","article-title":"Surveillance of vaccination coverage among adult populations - United States, 2015","volume":"66","author":"Williams","year":"2017","journal-title":"Morbidity and mortality weekly report. surveillance summaries (Washington, D.C.\u202f: 2002)"},{"issue":"2","key":"10.1016\/j.humimm.2026.112082_bb0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/advances\/nmy084","article-title":"Glutamine metabolism in macrophages: a novel target for obesity\/type 2 diabetes","volume":"10","author":"Ren","year":"2019","journal-title":"Advances in nutrition (Bethesda, Md.)"},{"issue":"1","key":"10.1016\/j.humimm.2026.112082_bb0065","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2482285","article-title":"Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: a narrative review","volume":"21","author":"Yewale","year":"2025","journal-title":"Hum. Vaccin. Immunother."},{"issue":"9","key":"10.1016\/j.humimm.2026.112082_bb0070","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.humimm.2026.112082_rf0075","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180238","article-title":"Structural and immunological characterization of E. coli derived recombinant CRM197 protein used as carrier in conjugate vaccines","volume":"38","author":"Mishra","year":"2018","journal-title":"Bioscience reports"},{"issue":"7","key":"10.1016\/j.humimm.2026.112082_rf0080","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.vaccine.2019.12.023","article-title":"Peripheral CD4 T follicular cells induced by a conjugated pneumococcal vaccine correlate with enhanced opsonophagocytic antibody responses in younger individuals","volume":"38","author":"Sterrett","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.humimm.2026.112082_bb0080","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","article-title":"Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire","volume":"104","author":"Weller","year":"2004","journal-title":"Blood"},{"issue":"79","key":"10.1016\/j.humimm.2026.112082_bb0085","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.ade1413","article-title":"T-independent responses to polysaccharides in humans mobilize marginal zone B cells prediversified against gut bacterial antigens","volume":"8","author":"Weller","year":"2023","journal-title":"Sci. Immunol."},{"issue":"Supplement","key":"10.1016\/j.humimm.2026.112082_bb0090","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.4103\/lungindia.lungindia_272_20","article-title":"Clinical practice guidelines 2019: Indian consensus-based recommendations on pneumococcal vaccination for adults","volume":"37","author":"Dhar","year":"2020","journal-title":"Lung India\u202f: official organ of Indian Chest Society"},{"issue":"10","key":"10.1016\/j.humimm.2026.112082_bb0095","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3201\/eid2610.191531","article-title":"Effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in adults, Japan, 2013-2017","volume":"26","author":"Shimbashi","year":"2020","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.humimm.2026.112082_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2328963","article-title":"Strategies for pneumococcal vaccination in older adults in the coming era","volume":"20","author":"Nakashima","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.humimm.2026.112082_bb0105","doi-asserted-by":"crossref","unstructured":"Xinning Tong, Le Gao, Ian C K Wong, Vivien K Y Chan, Angel Y S Wong, Judith C W Mak, Jacqueline K Y Yuen, Mark Jit, Ivan F N Hung, Kai Hang Yiu, Xue Li, Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort study, Int. J. Epidemiol., Volume 53, Issue 1, February 2024, dyae005, Doi:https:\/\/doi.org\/10.1093\/ije\/dyae005.","DOI":"10.2139\/ssrn.4397039"},{"key":"10.1016\/j.humimm.2026.112082_bb0110","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s15010-023-02054-3","article-title":"Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipients","volume":"51","author":"M\u00fclling","year":"2023","journal-title":"Infection"},{"issue":"5","key":"10.1016\/j.humimm.2026.112082_bb0115","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1177\/09612033231153535","volume":"32","author":"Rezende","year":"2023","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.humimm.2026.112082_bb0120","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4155\/bio-2023-0111","article-title":"Validation and comprehensive analysis of Streptococcus pneumoniae IgG WHO enzyme-linked immunosorbent assay in an Indian reference laboratory","volume":"16","author":"Shincy","year":"2024","journal-title":"Bioanalysis"},{"key":"10.1016\/j.humimm.2026.112082_bb0125","unstructured":"Training manual for enzyme linked immunosorbent assay for the quantitation of Streptococcus pneumoniae serotype specific IgG, Pn PS ELISA), 007sp Version."},{"issue":"3","key":"10.1016\/j.humimm.2026.112082_bb0130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14760584.2021.1889374","article-title":"Immunogenicity following revaccination or sequential vaccination with 23-valent pneumococcal polysaccharide vaccine (PPSV23) in older adults and those at increased risk of pneumococcal disease: a review of the literature","volume":"20","author":"Cripps","year":"2021","journal-title":"Expert Review of Vaccines"},{"issue":"35","key":"10.1016\/j.humimm.2026.112082_bb0135","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2026.112082_bb0140","doi-asserted-by":"crossref","unstructured":"Frenck, R. W., Jr, Fiquet, A., Gurtman, A., van Cleeff, M., Davis, M., Rubino, J., Smith, W., Sundaraiyer, V., Sidhu, M., Emini, E. A., Gruber, W. C., Scott, D. A., Schmoele-Thoma, B., & B1851020 Study Group (2016). Immunogenicity and safety of a second administration of 13-valent pneumococcal conjugate vaccine 5 years after initial vaccination in adults 50 years and older. Vaccine, 34(30), 3454\u20133462. https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.093.","DOI":"10.1016\/j.vaccine.2016.04.093"},{"issue":"3","key":"10.1016\/j.humimm.2026.112082_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arbres.2022.12.015","article-title":"Pneumococcal vaccination in adults: what can we learn from observational studies that evaluated PCV13 and PPV23 effectiveness in the same population?","volume":"59","author":"Dunne","year":"2023","journal-title":"Archivos de bronconeumologia"},{"issue":"6","key":"10.1016\/j.humimm.2026.112082_bb0150","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3201\/eid3006.230975","article-title":"Follow-up study of effectiveness of 23-valent pneumococcal polysaccharide vaccine against all-type and serotype-specific invasive pneumococcal disease, Denmark","volume":"30","author":"Nielsen","year":"2024","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.humimm.2026.112082_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0306921","article-title":"Naturally acquired antibodies against 4 Streptococcus pneumoniae serotypes in Pakistani adults with type 2 diabetes mellitus","volume":"19","author":"Ahmad","year":"2024","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.humimm.2026.112082_bb0160","doi-asserted-by":"crossref","first-page":"E551","DOI":"10.1111\/1469-0691.12286","article-title":"Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study","volume":"19","author":"urner","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.humimm.2026.112082_bb0165","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.vaccine.2022.12.060","article-title":"Safety and immunogenicity of sequential administration of PCV13 followed by PPSV23 in pneumococcal vaccine-na\u00efve adults aged \u2265 65 years: comparison of booster effects based on intervals of 0.5 and 1.0 year","volume":"41","author":"Azuma","year":"2023","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.humimm.2026.112082_bb0170","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1080\/21645515.2021.1888621","article-title":"Sequential administration of Prevnar 13\u2122 and PNEUMOVAX\u2122 23 in healthy participants 50 years of age and older","volume":"17","author":"Buchwald","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"35","key":"10.1016\/j.humimm.2026.112082_bb0175","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.vaccine.2013.04.084","article-title":"Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.humimm.2026.112082_bb0180","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/CVI.00110-08","article-title":"Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins","volume":"15","author":"Simell","year":"2008","journal-title":"Clinical and vaccine immunology : CVI"},{"issue":"2","key":"10.1016\/j.humimm.2026.112082_bb0185","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0091-6749(98)70089-2","article-title":"Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations","volume":"102","author":"Sorensen","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2026.112082_bb0190","doi-asserted-by":"crossref","unstructured":"P. Balmer, R. Borrow, J. Findlow, R. Warrington, S. Frankland, P. Waight, R. George, N. Andrews, E. Miller, Age-stratified prevalences of pneumococcal-serotype-specific 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate Doi:https:\/\/doi.org\/10.1128\/CVI.00264-07.","DOI":"10.1128\/CVI.00264-07"},{"issue":"4","key":"10.1016\/j.humimm.2026.112082_bb0195","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1128\/JCM.01937-09","article-title":"Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease","volume":"48","author":"Im\u00f6hl","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"20","key":"10.1016\/j.humimm.2026.112082_bb0200","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.vaccine.2014.02.002","article-title":"Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-na\u00efve adults 60-64 years of age","volume":"32","author":"Greenberg","year":"2014","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.humimm.2026.112082_bb0205","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.vaccine.2013.05.010","article-title":"Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine","volume":"31","author":"Jackson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2026.112082_bb0210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1152\/physiol.00035.2015","article-title":"Sex and gender impact immune responses to vaccines among the elderly","volume":"30","author":"Fink","year":"2015","journal-title":"Physiology"},{"key":"10.1016\/j.humimm.2026.112082_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1707507","article-title":"Diabetes as an independent risk factor for severe inflammatory bowel disease: evidence from an inflammation-metabolism-liver coupling framework","volume":"16","author":"Huang","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.humimm.2026.112082_bb0220","doi-asserted-by":"crossref","unstructured":"Xujiu, W., & Li, Z. (2026). Protein tyrosine phosphatase 1B protein macromolecule combined with aerobic exercise intervention on lipid metabolism in type II diabetes patients. Arch. Physiol. Biochem., 1\u20139. Advance online publication. Doi:https:\/\/doi.org\/10.1080\/13813455.2026.2628187.","DOI":"10.1080\/13813455.2026.2628187"},{"issue":"1","key":"10.1016\/j.humimm.2026.112082_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ibd.21668","article-title":"Inadequate knowledge of immunization guidelines: a missed opportunity for preventing infection in immunocompromised IBD patients","volume":"18","author":"Yeung","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.humimm.2026.112082_bb0230","first-page":"15","article-title":"Survey of vaccination practices in patients with diabetes: a report examining patient and provider perceptions and barriers","volume":"9","author":"Alvarez","year":"2017","journal-title":"J. Clin. Transl. Endocrinol."},{"issue":"12","key":"10.1016\/j.humimm.2026.112082_bb0235","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.4161\/hv.25826","article-title":"The effect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological study \"diaVAX\"","volume":"9","author":"Satman","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"issue":"7","key":"10.1016\/j.humimm.2026.112082_bb0240","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1080\/21645515.2019.1692564","article-title":"Adult vaccination in India: status and the way forward","volume":"16","author":"Lahariya","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"issue":"6","key":"10.1016\/j.humimm.2026.112082_bb0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2471\/BLT.21.287390","article-title":"Vaccination coverage among older adults: a population-based study in India","volume":"100","author":"Rizvi","year":"2022","journal-title":"Bull. World Health Organ."},{"issue":"21","key":"10.1016\/j.humimm.2026.112082_bb0250","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.vaccine.2021.04.015","article-title":"Pneumococcal serotype-specific cut-offs based on antibody responses to pneumococcal polysaccharide vaccination in healthy adults","volume":"39","author":"Park","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.humimm.2026.112082_bb0255","doi-asserted-by":"crossref","unstructured":"Fuji, N., Pham, M., Kaur, R., & E Pichichero, M. (2024). Serotype 3 antibody response and antibody functionality compared to serotype 19A following 13-valent pneumococcal conjugate immunization in children. Pediatr. Infect. Dis. J., 43(3), 294\u2013300. Doi:https:\/\/doi.org\/10.1097\/INF.0000000000004192.","DOI":"10.1097\/INF.0000000000004192"},{"key":"10.1016\/j.humimm.2026.112082_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126635","article-title":"The safety and efficacy of inactivated COVID-19 vaccination in couples undergoing assisted reproductive technology: a prospective cohort study","volume":"45","author":"Yang","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.humimm.2026.112082_bb0265","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2217076","article-title":"Sweet syndrome induced by SARS-CoV-2 vaccines: a systematic review of patient-report studies","volume":"19","author":"Jia","year":"2023","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926004283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926004283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T13:13:11Z","timestamp":1795180391000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926004283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0198885926004283"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112082","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneous serotype-specific immune responses following sequential PCV13-PPSV23 vaccination in adults with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.112082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112082"}}